Figure 1.
SGLT2 protein with TM domains defined by AA#.31 Graphed are all known protein altering pathogenic/likely pathogenic variants (blue)9,10 and novel variants associated with renal or all glucosuria (red). *Variants studied in the prospective trial. AA#, amino acid number; SGLT2, sodium-glucose cotransporter-2; TM, transmembrane.
